Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Docetaxel monotherapy is one of the standard treatments for non-small-cell lung cancer in elderly patients. The addition of bevacizumab to docetaxel seems promising; however, the feasibility of this combination has not been investigated in such patients. |